Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05104_nanopub.RA4qvwWTT9WJmqSsb8SplHhMsboBvLWbtZ0osGc4ttn-Q#assertion>. }
Showing items 1 to 15 of
15
with 100 items per page.
- drugbank:DB05104 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05104 label "Asimadoline [drugbank:DB05104]" assertion.
- drugbank:DB05104 seeAlso DB05104 assertion.
- drugbank:DB05104 description "Asimadoline is a proprietary small molecule therapeutic, originally discovered by Merck KGaA of Darmstadt, Germany. Asimadoline was originally developed to treat peripheral pain such as arthritis. Asimadoline is an orally administered agent that acts as a kappa opioid receptor agonist. It has shown encouraging clinical efficacy for the treatment of IBS in a barostat study in IBS patients and has the potential for treating other gastrointestinal diseases." assertion.
- drugbank:DB05104 identifier "drugbank:DB05104" assertion.
- drugbank:DB05104 title "Asimadoline" assertion.
- drugbank:DB05104 drugbank_vocabulary:x-pubchemsubstance pubchem.substance:10259055 assertion.
- drugbank:DB05104 drugbank_vocabulary:x-pubchemcompound pubchem.compound:179340 assertion.
- drugbank:DB05104 drugbank_vocabulary:x-chemspider chemspider:156107 assertion.
- drugbank:DB05104 drugbank_vocabulary:x-cas cas:153205-46-0 assertion.
- drugbank:DB05104 drugbank_vocabulary:drugbank-id "DB05104" assertion.
- drugbank:DB05104 bio2rdf_vocabulary:x-identifiers.org DB05104 assertion.
- drugbank:DB05104 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05104" assertion.
- drugbank:DB05104 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05104 bio2rdf_vocabulary:identifier "DB05104" assertion.